Friends,
Forgive me for my lack of posting. I have been living out of a suitcase for more than a month now. Please take a look at my latest post, an interview with Dr. Farooqui out of the NIH that shares important news about research at the NIH, ABT-199, and also my personal news.
Stay strong
Many thanks Brian for the Blog update, great videos.
Your forgiveness is automatic.
Great to see continued good news on the ABT-199 comeback, and the possibilities with that.
And the very best of luck with the refocussing of the lecturing activities.
Best Regards,
Ernest.
Informative interview and video. Thank you for posting.
ASCO 2014: Dr. Susan O'Brien Reviews the 3 years follow-up Data on Ibrutinib in CLL
Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell CLLMy 1 year CAR-T anniversary and from ASH 2018, Dr. Siddiqi on how CLL treatment has changed.
IVIG seems to have shared some antibodies from previous COVID patient
Decision made, approval received. Will be starting Acalabrutinib at NIH
